CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 63 enrolled
Drug / intervention
Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05503758
NCT05503758N/ACompleted
CompareCT.gov

Quantification of Different Lumbar Paravertebral Muscles Properties in Women Who Experienced Cesarean Delivery Under Different Types of Anaesthesia

South Valley University·observational·Posted Aug 17, 2022·Updated Oct 2, 2025

In Brief

An observational study evaluating Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia) for Lumbar Paravertebral Muscles. Completed, enrolled 63 participants across 1 site.

Detailed Summary

Cesarean delivery (CD) is an obstetric surgery for fetal delivery that involves both an abdominal incision (laparotomy) and a uterine incision (hysterotomy). It is presently the most prevalent surgery in the United States, with over 1 million women giving birth by cesarean section each year.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLumbar Paravertebral Muscles
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 17, 2022
Enrollment StartJun 28, 2021
Primary CompletionJan 29, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.9 years ago

Interventions

Myoton PRO device (MyotonPRO; Myoton AS, Tallinn, Estonia)device

The MyotoPRO device is a portable objective device for measuring the contractile (tone), and biomechanical (stiffness) properties of lumbar paravertebral muscles (LPVMs).